These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9809504)

  • 21. Evaluating therapeutic targets for reperfusion-related brain hemorrhage.
    Maier CM; Hsieh L; Crandall T; Narasimhan P; Chan PH
    Ann Neurol; 2006 Jun; 59(6):929-38. PubMed ID: 16673393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
    Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y
    Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression].
    Ntayi C; Hornebeck W; Bernard P
    Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.
    Bradley JM; Vranka J; Colvis CM; Conger DM; Alexander JP; Fisk AS; Samples JR; Acott TS
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2649-58. PubMed ID: 9856774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The serine proteases and their function in neuronal death processes].
    Fuster Lluch O; Galindo MF; Ceña V; Jordán J
    Rev Neurol; 2004 Mar 1-15; 38(5):449-57. PubMed ID: 15029525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat.
    Amantea D; Russo R; Gliozzi M; Fratto V; Berliocchi L; Bagetta G; Bernardi G; Corasaniti MT
    Int Rev Neurobiol; 2007; 82():149-69. PubMed ID: 17678960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
    Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
    J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental microvascular and clotting changes--significance for acute stroke therapy].
    Wagner S; Hamann GF
    Nervenarzt; 2003 Feb; 74(2):123-32. PubMed ID: 12596013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases in neuroinflammation.
    Rosenberg GA
    Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of matrix metalloproteinases in delayed cortical responses after stroke.
    Zhao BQ; Wang S; Kim HY; Storrie H; Rosen BR; Mooney DJ; Wang X; Lo EH
    Nat Med; 2006 Apr; 12(4):441-5. PubMed ID: 16565723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine protease inhibitors: novel therapeutic targets for stroke?
    Vivien D; Buisson A
    J Cereb Blood Flow Metab; 2000 May; 20(5):755-64. PubMed ID: 10826525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes.
    Hauzenberger D; Bergström SE; Klominek J; Sundqvist KG
    Anticancer Res; 1999; 19(3A):1945-52. PubMed ID: 10470139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
    Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C
    J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.
    Gasche Y; Copin JC; Sugawara T; Fujimura M; Chan PH
    J Cereb Blood Flow Metab; 2001 Dec; 21(12):1393-400. PubMed ID: 11740200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
    Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions.
    Wang Y; Luo W; Reiser G
    Cell Mol Life Sci; 2008 Jan; 65(2):237-52. PubMed ID: 17965832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
    van Hinsbergh VW; Koolwijk P
    Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.